MPS II patients presented higher levels of pro-inflammatory and pro-oxidant biomarkers.
Lipid peroxidation and oxidative protein damage occurred in MPS II patients.
No alterations of enzymatic and non-enzymatic defenses were observed in MPS II patients.
MPS II patients presented higher levels of reactive nitrogen species.
Nitrative stress and protein damage were positively correlated to GAG accumulation.